IP Library › Granted Patent US 7,273,922
Granted Patent B2
US 7,273,922 · App. 10/391,413 · Granted Sep 25, 2007

Semaphorin Z and gene encoding the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,273,922
App. No.
10/391,413
Granted
Sep 25, 2007
Kind
B2
Abstract

Novel semaphorin Z; a gene thereof; a partial peptide of the semaphorin Z; an antibody; a DNA or an RNA complementary to the semaphorin Z gene; a method for screening a semaphorin Z inhibitor by using the semaphorin Z; the semaphorin Z inhibitor obtained by the screening; and a CNS neuron regeneration promoter comprising the inhibitor.

Claims (3)

1. An isolated polypeptide comprising the amino acid sequence shown in SEQ ID NO:4.

2. An isolated polypeptide encoded by the nucleotide sequence comprising SEQ ID NO:3.

3. An isolated polypeptide obtained by expressing in a cell a nucleic acid comprising (a) the nucleotide sequence of SEQ ID NO:3, (b) the nucleotide sequence of SEQ ID NO:3 from nucleotide 39 to nucleotide 2702 or (c) a nucleotide sequence encoding the amino acid sequence of SEQ ID NO:4; and purifying the encoded polypeptide.

Assignments (1)
MERGER Recorded Dec 16, 2005
From: SUMITOMO PHARMACEUTICALS COMPANY, LTD.
To: DAINIPPON SUMITOMO PHARMA CO., LTD.
Reel/Frame 017089/0420 →